Skip to main content
Clinical Trials/JPRN-UMIN000009329
JPRN-UMIN000009329
Completed
Phase 2

Study of Clinical Usefulness of 18F-fluorothymidine(FLT) PET/CT in Ditection of Peritoneal Metastases of Gastric Cancer - Study of Usefulness of 18F-FLT PET/CT in Peritoneal Metastases of Gastric Cancer

Department of Gastrointestinal Oncology, National Cancer Center Hospital in Japan0 sites40 target enrollmentNovember 13, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Gastrointestinal Oncology, National Cancer Center Hospital in Japan
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 13, 2012
End Date
May 1, 2015
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastrointestinal Oncology, National Cancer Center Hospital in Japan

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Peritoneal metastases detected only by cytology of ascites. 2\.Patients who have alcoholic hyper\- sensitivity. 3\.Patients with active infection. 4\.Pregnant women or women who have the possibility to be pregnant or lactating woman. 5\.Patients who are considered to be ineligible by referring physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials